Defense Production Act Determination for COVID-19 Vaccine Production
🏥 Healthcare · First Term (2017–2021) · 🤖 AI-categorized
On June 24, 2020, the Trump administration issued a Presidential Determination under Section 303 of the Defense Production Act of 1950, invoking authority to prioritize defense contracts related to COVID-19 vaccine manufacturing. The determination authorized the government to allocate materials and resources to vaccine production facilities. The confirmed effect was to establish priority rating authority for contracts supporting vaccine development and manufacturing capacity during the pandemic.